- Action
- Philips Healthcare issued a Field Safety Notification (FSN)72800720/88200522
1. Identify affected product
2. There are 3 scenarios users may experience which result in identical images that are incorrectly labeled as phase tolerance images.
A. When performing a Step and Shoot acquisition with phase tolerance
selected, images may be reconstructed identically (a single phase), but
are labeled as different phases. This occurs when Start Final Recon
is selected prior to display of the ECG wave at the top of the
acquisition window.
B. When performing a Step and Shoot acquisition with phase tolerance
selected, images may be reconstructed identically (a single phase), but
are labeled as different phases. This occurs if ECG leads become
disconnected mid-acquisition or when the acquisition is halted
prematurely due to an application crash.
C. By system design, in certain instances when a patient exhibits an
arrhythmia or varying heart rate during a Step and Shoot acquisition,
images from the acquisition following the heart rate variation, may be
labeled in the incorrect phase
4. Determine whether you have a potentially affected system, then determine your AFFECTED PRODUCTS software version. To identify the software version of your product: Click the Help button, Select About and the software version is then displayed, Software versions 4.x, 3.x, and 2.x are potentially affected.
5. Take the Action listed in the field safety notice.
Please retain a copy with the equipment Instruction for use.
If you need any further information or support concerning this issue, please
contact your local Philips representative: North America and Canada, contact the Customer Care Solutions Center (1-800-722-9377 and follow the prompts).
- Initiated
- 2019-06-24
- Root cause
- Other
- Terminated
- 2022-10-06
- Distribution
- Worldwide distribution. US nationwide including Puerto Rico, Canada, Mexico, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Bulgaria, Cambodia, Cayman Islands, Chile, China, Colombia, Cote D'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, French Polynesia, Gabon, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Guyana, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Macedonia, Malawi, Malaysia, Maldives, Mali, Malta, Martinique, Mauritius, Monaco, Mongolia, Morocco, Mozambique, Myanmar, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, State of Palestine, Panama, Peru, Philippines, Poland, Qatar, Reunion, Romania, Russian Federation, Rwanda, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tanzania, Thailand, Timor-Leste, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan, Venezuela, Viet Nam, and Yemen
- Recall number
- Z-2188-2019
- Recall status
- Terminated
- CDRH record ID
- 174967
- FDA classified
- 2019-08-06
- Recall event number
- 83365